CHRISTOPHER FOTI: Open Payments
NPI 1770577389 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 33 payments from 10 companies in 2025. Trend: 2023 $1,549 · 2024 $1,040 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $224 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| ABBVIE INC. | 5 | $106 |
| Amgen Inc. | 4 | $88 |
| UCB, Inc. | 3 | $64 |
| Arcutis Biotherapeutics, Inc. | 3 | $63 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $25 |
| Organon LLC | 1 | $22 |
| Incyte Corporation | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: DUPIXENT, SKYRIZI, OTEZLA, Bimzelx, Zoryve, COSENTYX, Rhapsido, OPZELURA.
Industry payments across WV — which companies pay providers there.
